| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Olema Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 24.2K | Jun 11, 2025 | Direct | ||
| Kymera Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 16K | Jun 25, 2025 | Direct | ||
| Rain Oncology Inc. | Director | Stock Option (Right to Buy) | 0 | Jan 26, 2024 | Direct |